Surgery Versus Ablation for Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF-RCT Trial) and a Nonrandomized Prospective Observational Trial (SURF-Cohort Trial) Personalized dosing of ...
Semaglutide (better known as Wegovy) may help people with obesity lose up to 25% of their body weight when used at a higher ...
The STEP UP trial reveals semaglutide 7.2 mg significantly reduces weight compared to 2.4 mg, though it raises questions ...
A new drug from California-based pharma company Amgen, which has concluded a phase II trial, shows promise as a powerful treatment for obesity. With just a once-monthly shot of 'MariTide,' ...
Adjusted body weight is used to calculate weight, which considers lean and fat mass. This tool can help provide more precise medical and nutritional assessments. Healthcare professionals often use ...
VENICE, ITALY — Personalized doses and slow tapering of semaglutide (Wegovy or Ozempic, Novo Nordisk) in patients who also follow a digital weight loss program can lead to maintenance of target weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback